Oncometabolites as biomarkers in thyroid cancer: a systematic review
- PMID: 30881111
- PMCID: PMC6395057
- DOI: 10.2147/CMAR.S188661
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Abstract
Introduction: Thyroid cancer (TC) is an important common endocrine malignancy, and its incidence has increased in the past decades. The current TC diagnosis and classification tools are fine-needle aspiration (FNA) and histological examination following thyroidectomy. The metabolite profile alterations of thyroid cells (oncometabolites) can be considered for current TC diagnosis and management protocols.
Methods: This systematic review focuses on metabolite alterations within the plasma, FNA specimens, and tissue of malignant TC contrary to benign, goiter, or healthy TC samples. A systematic search of MEDLINE (PubMed), Scopus, Embase, and Web of Science databases was conducted, and the final 31 studies investigating metabolite biomarkers of TC were included.
Results: A total of 15 targeted studies and 16 untargeted studies revealed several potential metabolite signatures of TC such as glucose, fructose, galactose, mannose, 2-keto-d-gluconic acid and rhamnose, malonic acid and inosine, cholesterol and arachidonic acid, glycosylation (immunoglobulin G [IgG] Fc-glycosylation), outer mitochondrial membrane 20 (TOMM20), monocarboxylate transporter 4 (MCT4), choline, choline derivatives, myo-/scyllo-inositol, lactate, fatty acids, several amino acids, cell membrane phospholipids, estrogen metabolites such as 16 alpha-OH E1/2-OH E1 and catechol estrogens (2-OH E1), and purine and pyrimidine metabolites, which were suggested as the TC oncometabolite.
Conclusion: Citrate was suggested as the first most significant biomarker and lactate as the second one. Further research is needed to confirm these biomarkers as the TC diagnostic oncometabolite.
Keywords: TC; biomarkers; oncometabolites; systematic review; thyroid cancer.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
The metabolomics and lipidomics window into thyroid cancer research.Biomarkers. 2017 Nov;22(7):595-603. doi: 10.1080/1354750X.2016.1256429. Epub 2016 Nov 15. Biomarkers. 2017. PMID: 27805426
-
Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.Semin Oncol. 2017 Jun;44(3):218-225. doi: 10.1053/j.seminoncol.2017.10.003. Epub 2017 Oct 10. Semin Oncol. 2017. PMID: 29248133 Free PMC article.
-
An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter.Onco Targets Ther. 2016 Sep 22;9:5819-5823. doi: 10.2147/OTT.S111275. eCollection 2016. Onco Targets Ther. 2016. PMID: 27703381 Free PMC article.
-
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.Biomed Res Int. 2017;2017:2545031. doi: 10.1155/2017/2545031. Epub 2017 Nov 6. Biomed Res Int. 2017. PMID: 29234677 Free PMC article. Review.
-
Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.Endocr Relat Cancer. 2023 Oct 26;30(12):e230002. doi: 10.1530/ERC-23-0002. Print 2023 Dec 1. Endocr Relat Cancer. 2023. PMID: 37882489
Cited by
-
Evolutionary View on Lactate-Dependent Mechanisms of Maintaining Cancer Cell Stemness and Reprimitivization.Cancers (Basel). 2022 Sep 20;14(19):4552. doi: 10.3390/cancers14194552. Cancers (Basel). 2022. PMID: 36230479 Free PMC article. Review.
-
Malignant and benign thyroid nodule differentiation through the analysis of blood plasma with terahertz spectroscopy.Biomed Opt Express. 2021 Jan 26;12(2):1020-1035. doi: 10.1364/BOE.412715. eCollection 2021 Feb 1. Biomed Opt Express. 2021. PMID: 33680557 Free PMC article.
-
TiO2@COF-based solid-phase microextraction combined with UHPLC-MS/MS for the rapid determination of potential biomarkers of phosphatidylcholines and lysophosphatidylcholines in head and neck cancers.Anal Bioanal Chem. 2023 Nov;415(27):6771-6783. doi: 10.1007/s00216-023-04954-7. Epub 2023 Sep 30. Anal Bioanal Chem. 2023. PMID: 37776352
-
Direct mass spectrometry analysis of biological tissue for diagnosis of thyroid cancer using wooden-tip electrospray ionization.Front Chem. 2023 Feb 9;11:1134948. doi: 10.3389/fchem.2023.1134948. eCollection 2023. Front Chem. 2023. PMID: 36846859 Free PMC article.
-
Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer.Metabolites. 2022 Dec 3;12(12):1214. doi: 10.3390/metabo12121214. Metabolites. 2022. PMID: 36557253 Free PMC article. Review.
References
-
- Vergamini LB, Frazier AL, Abrantes FL, Ribeiro KB, Rodriguez-Galindo C. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J Pediatr. 2014;164(6):1481–1485. - PubMed
-
- Larijani B, Shirzad M, Mohagheghi MA, et al. Epidemiologic analysis of the Tehran cancer institute data system registry (TCIDSR) Asian Pac J Cancer Prev. 2004;5(1):36–39. - PubMed
-
- Haghpanah V, Soliemanpour B, Heshmat R, et al. Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer. 2006;43(2):80. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous